BSE: SANOFI - Sanofi India Limited

Rentabilidade por seis meses: -12.85%
Rendimento de dividendos: +1.51%

Cronograma de promoção Sanofi India Limited

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa Sanofi India Limited

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional health under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Glimepiride, Cetapin, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors.

mais detalhes
It also exports its products to approximately 35 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

ISIN INE058A01010
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 1.71
Дивиденд ао 68.21
Сайт https://www.sanofiindialtd.com
Цена ао 5592.35
Alteração de preço por dia: -0.4488% (5592.35)
Alteração de preço por semana: -6.84% (5976.1)
Alteração de preço por mês: -10.28% (6205.25)
Alteração de preço em 3 meses: -18.95% (6869)
Mudança de preço em seis meses: -12.85% (6388.45)
Mudança de preço por ano: -32.38% (8233.25)
Mudança de preço em 3 anos: -25.95% (7518.15)
Mudança de preço em 5 anos: -20.95% (7042.75)
Mudança de preço em 10 anos: 0% (5567.25)
Mudança de preço desde o início do ano: -10.76% (6238.8)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 6.55 1
P/BV 18.17 1
P/E 30.59 5
EV/EBITDA 17.69 6
Total: 4.63

Eficiência

Nome Significado Nota
ROA, % 35.16 9
ROE, % 59.39 10
Total: 5.83

Dividendos

Nome Significado Nota
Div yield, % 1.51 3.78
DSI 0.8571 8.57
Total: 4.94

Obrigação

Nome Significado Nota
Debt/EBITDA 0.026 10
Total: 10

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % -8.24 0
Rentabilidade Ebitda, % 20.55 4
Rentabilidade EPS, % 50.5 7
Total: 3.4
Mais detalhes

ETF Compartilhar, % Rentabilidade para o ano, % Dividendos, %
iShares MSCI India Small-Cap ETF 0.16695 0.4625 0.96163
SPDR S&P Emerging Markets Small Cap ETF 0.07114 5.46 3.03583
iShares MSCI Emerging Markets Small-Cap ETF 0.04483 7.67 2.7853
Avantis Emerging Markets Value ETF 0.03441 14.12 4.22231
Avantis Responsible Emerging Markets Equity ETF 0.02777 17.6 3.1719
Vanguard FTSE All-World ex-US Small-Cap ETF 0.02 9.39 3.09932
Avantis Emerging Markets Equity ETF 0.01484 8.77 3.60513
Dimensional Emerging Markets Core Equity 2 ETF 0.0079 15.96 3.34087
Dimensional World ex U.S. Core Equity 2 ETF 0.00469 13.06 3.62488
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.00447 12.46 3.59676

Supervisor Cargo Pagamento Ano de nascimento
Mr. Rodolfo Hrosz MD & Director 17.85M 1967 (58 anos)
Mr. M. K. Narayanaswamy B.Com.,A.I.C.W.A. Senior Director of Accounting & Taxation N/A 1955 (70 anos)
Mr. Sanjay V. Chavan Head of Country Procurement - India N/A 1962 (63 ano)
Ms. Surabhi Kaur People & Culture Director N/A
Ms. Renee Amonkar Additional Whole Time Director N/A
Mr. Rachid Ayari CFO & Whole Time Director N/A
Ms. Flovie Martins Head of Corporate Communications & Corporate Social Responsibility
Nakul Verma Senior Director of Public Affairs
Yasmin Shenoy Senior Director of Regulatory Affairs
Mr. N. Suresh Babu Sales & Customer Engagement Head - Diabetes and Senior Director of Diabetes

Endereço: India, Mumbai, Sanofi House - abrir no Google Maps, abrir mapas Yandex
Site: https://www.sanofiindialtd.com